Delayed onset of Igf2-induced mammary tumors in Igf2r transgenic mice

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• The insulin-like growth factor-II (IGF-II) receptor (IGF2R) regulates proteins controlling growth and differentiation.
• Loss of IGF2R in tumors suggests a tumor suppressor role, but the specific functions are unclear.
• IGF2R's proposed tumor suppressor mechanism involves lysosomal degradation of IGF-II.

Purpose of the Study:

• To genetically test the hypothesis that IGF2R's tumor suppressor function is mediated by IGF-II degradation.
• To investigate the in vivo effects of Igf2r transgene expression on mammary tumor development.

Main Methods:

• Generated Igf2r transgenic mice with ubiquitous transgene expression.
• Crossed Igf2r transgenic mice with mice overexpressing Igf2, which develop mammary tumors.
• Assessed the impact of Igf2r transgene on mammary tumor onset and multiplicity.

Main Results:

• The presence of the Igf2r transgene significantly delayed mammary tumor onset in Igf2 transgenic mice.
• Igf2r transgene expression decreased tumor multiplicity in the context of Igf2 overexpression.
• These findings support a role for IGF2R in suppressing mammary tumor formation.

Conclusions:

• The Igf2r transgene confers a tumor-suppressive effect on mammary tumorigenesis driven by Igf2 overexpression.
• These results are relevant to human tumors and preneoplastic conditions with altered IGF2 expression.
• This study provides in vivo genetic evidence for IGF2R's tumor suppressor function related to IGF-II regulation.